| 產品詳情 |
| Edit |   |
|---|
| Product Name | Recombinant Human JAM-B/VE-JAM Fc Chimera Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 64-70 kDa, reducing conditions. MW (theoretical): 50 kDa (monomer). The Recombinant Human JAM-B/VE-JAM Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human JAM-B/VE-JAM Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 50 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | C21orf43, CD322, CD322 antigen, JAM2, JAMB, JAM-BJAM-IT/VE-JAM, junctional adhesion molecule 2JAM-2, junctional adhesion molecule B, PRO245, Vascular endothelial junction-associated molecule, VE-JAM, VE-JAMVEJAMCD322 |
|---|
| Gene, Accession, CAS # | JAM2, Gene ID: 58494, Accession: P57087 |
|---|
| Catalog # | 1074-VJ-050 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Human JAM-B/VE-JAM Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | PubMed: 24357068 |
|---|
| 產品資料 |
|
|